Lantheus Holdings, Inc. completed its acquisition of Life Molecular Imaging Limited on July 21, 2025, paying $350 million for the entire issued share capital. Additionally, they appointed Dr. Ludger Dinkelborg as the new Head of Research and Development, effective August 1, 2025.